Showing results (11-20 of 223) with videos related to
Sort By:
Pageof 23
Journal of Medical Virology|March 21, 2012
Minority HIV-1 resistant variants in recent infection and in patients who failed first-line antiretroviral therapy with no detectable resistance-associated mutations in ThailandHai Le Nguyen, Patrawadee Pitakpolrat, Sunee Sirivichayakul, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 12, 2014
Loss of anti-hepatitis C virus antibodies following therapeutic sustained virological response in a HIV co-infected patientSarah Maylin, Nathalie Colin de Verdière, Maud Salmona, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 4, 2024
Does the ultrasensitive HBsAg Next assay enhance Hepatitis B diagnosis? An evaluation of analytical performancesJoachim Bourdin, Pierre Sellier, Maud Salmona, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 31, 2015
Comparison of the bioMérieux NucliSENS EasyQ HIV-1 v2.0-HIV-1 RNA quantification assay versus Abbott RealTime HIV-1 and Roche Cobas TaqMan HIV-1 v2.0 on current epidemic HIV-1 variantsThomas Mourez, Constance Delaugerre, Muriel Vray, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 22, 2005
Selection of a rare resistance profile in an HIV-1-infected patient exhibiting a failure to an antiretroviral regimen including tenofovir DFConstance Delaugerre, Laurent Roudiere, Gilles Peytavin, et al.AIDS (London, England)|August 14, 2018
Accurate quantification of CXCR4-using HIV-1 variants by Illumina deep-sequencingStéphanie Raymond, Constance Delaugerre, Florence Nicot, et al.Journal of Medical Virology|July 30, 2014
Safety and efficacy of coformulated efavirenz/emtricitabine/tenofovir single-tablet regimen in treatment-naive patients infected with HIV-1Sébastien Gallien, Philippe Flandre, Nga Nguyen, et al.Open Forum Infectious Diseases|October 21, 2016
Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory AgentsHéloïse M Delagrèverie, Constance Delaugerre, Sharon R Lewin, et al.Journal of Virological Methods|January 2, 2010
Sensitivity of 8 CE (European Community)-approved rapid disposable tests for anti-HIV antibody detection during and after seroconversionEric Laforgerie, Béatrice Boucher, Thoi Dong Ly, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 11, 2014
Use of hepatitis B surface and "e" antigen quantification during extensive treatment with tenofovir in patients co-infected with HIV-HBVAnders Boyd, Sarah Maylin, Joël Gozlan, et al.Pageof 23